FBIO - Fortress Biotech GAAP EPS of -$1.03 beats by $0.70 revenue of $13M misses by $1.13M May, 15 2024 04:54 PM Fortress Biotech Inc. 2024-05-15 16:54:28 ET More on Fortress Biotech Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment Seeking Alpha’s Quant Rating on Fortress Biotech Historical earnings data for Fortress Biotech Financial information for Fortress Biotech For further details see: Fortress Biotech GAAP EPS of -$1.03 beats by $0.70, revenue of $13M misses by $1.13M